跳至主要内容
临床试验/NL-OMON53233
NL-OMON53233尚未招募4 期

Minimally Invasive versus Open Lumbar Interbody Fusion Trial (MIOLIFT): a randomized controlled trial for surgical treatment of lumbar spondylolisthesis and foraminal stenosis - MIOLIFT

Zuyderland Medisch Centrum0 个研究点目标入组 198 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
198

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Indication for MITLIF (minimal invasive transforaminal lumbar interbody
  • fusion) or OTLIF (open transforaminal lumbar interbody fusion) surgery.
  • - Clinical mono uni- or bilateral lumbar radiculopathy or intermittent
  • neurogenic claudication caused by a single level degenerative foraminal
  • stenosis or isthmic, iatrogenic, or degenerative spondylolisthesis gr I or II
  • according to Meyerding classification at level L3L4, L4L5 or L5S1.
  • - Age over 18 years.
  • - Single level degenerative foraminal stenosis or isthmic, iatrogenic, or
  • degenerative spondylolisthesis causing central stenosis on MRI (or CT), of
  • which the anatomical level is corresponding to the clinical syndrome.
  • - Psychosocially, mentally, and physically able to fully comply with this study
  • - Informed consent prior to this study.

排除标准

  • - Previous radiotherapy at the intended surgical level.
  • - (Progressive) motor failure and/or anal sphincter disorders which urges
  • instant intervention.
  • - Active spinal infection.
  • - Immature bone (on-going growth).
  • - Active malignancy.
  • - Pregnancy.
  • - Symptomatic osteoporosis (Current or previous use of bisphosphonates).
  • - Contra-indications for anaesthesia or surgery.
  • - Inadequate command of the Dutch language.

研究者

发起方
Zuyderland Medisch Centrum

相似试验